Qu Lin
department
Medical Oncology
Introduction

Qu Lin,MD, PhD.

?

Titles

Associated Professor and Vice Director of Oncology Department of the Third Affiliated Hospital?, Sun Yat-Sen University

?

Major Professional Societies

Vice Director of committee of the Targeted Therapy of Guangzhou Anti-cancer Association

Committee of Molecular Targeted Therapy Branch of ?Hospital Association of Guangdong Province

Committee, Oncology Branch of Guangzhou Medical Association

Committee, Internal Medicine Group of Oncology Branch of Guangdong Medical Association

Committee, ?Lymphoma Branch of Guangzhou Anti-cancer Association

?

Research Interests

Carcinogenesis of malignant lymphoma

Palliative therapy of advanced cancer

Prevention of neoplasms recurrence and metastasis

Molecular targeted therapy for malignant neoplams

?

Education and Experience

Education

·Bachelor: Sun Yat-Sen University of Medical Sciences, China (1989-1994)

·Master: Sun Yat-Sen University, China (1999-2002)

·M.D., PhD.: Sun Yat-Sen University (2004-2007)

Training

·Sun Yat-Sen Memorial Hospital,?Sun Yat-Sen University, China (1993-1994)

Residencies

·Internal medicine department of?Sun Yat-Sen Memorial Hospital, China (1994-1998)

·Internal medicine department of the 3rdAffiliated hospital, Sun Yat-Sen University, China (1998-1999)

The Attending Physician

·Hematology department of the third affiliated hospital, Sun Yat-Sen University, China (1999-2005)

·Oncology department of the third affiliated hospital, Sun Yat-Sen University China (2005-2007)

Associate Chief Physician

·Oncology department of the third affiliated hospital, Sun Yat-Sen University China (2007-Present)

?

Medical Specialty

·She specialized in chemotherapy, molecular target therapy and palliative therapy of malignant tumor. She especially is experted in malignant lymphoma, hepatocellular carcinoma and cholangiocarcinoma.

?

Honors and Awards

?

Publications

·Lin Q et al. Abnormal?high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment. Rheumatol Int. 2009 May 23.

·Lin Q et al. Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis. Chinese Medical Journal. 2009, 122(15):1784

·Ming-Sheng Huang,Qu Lin,Zai-Bo Jiang, et al. Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World Journal of Gastroenterl,2004,10(6):825

·Li X, Lin Q, Dong M, Wen JY, Wei L, Ma XK, Chen ZH, Wu XY* . ?Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma. Leuk Lymphoma. 2010, 51(9):1678-85. ( Corresponding author)

?

Contact

Oncology Department,

The Third Affiliated Hospital, Sun Yat-Sen University,

600 TianheRoad,Guangzhou City, Guanddong Province,
510630, China

Phone:+86-020-85252161

?

E-mail:

gzlinqu@163.com???

linqu@mail.sysu.edu.cn?